NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.14% | 26.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.14% | 26.77% | |||
| Cost of Revenue | -5.29% | 25.25% | |||
| Gross Profit | -9.59% | 33.34% | |||
| SG&A Expenses | 5.27% | 21.04% | |||
| Depreciation & Amortization | -2.53% | -0.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.80% | 23.87% | |||
| Operating Income | -54.73% | 147.38% | |||
| Income Before Tax | -94.86% | 361.98% | |||
| Income Tax Expenses | -19.25% | 15.43% | |||
| Earnings from Continuing Operations | -127.59% | 208.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 29.49% | -1.34% | |||
| Net Income | -159.57% | 164.80% | |||
| EBIT | -54.73% | 147.38% | |||
| EBITDA | -36.67% | 63.59% | |||
| EPS Basic | -160.61% | 164.71% | |||
| Normalized Basic EPS | -75.41% | 2,950.00% | |||
| EPS Diluted | -160.61% | 147.14% | |||
| Normalized Diluted EPS | -74.58% | 2,850.00% | |||
| Average Basic Shares Outstanding | -0.22% | 0.63% | |||
| Average Diluted Shares Outstanding | 0.19% | 1.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||